| Name | Title | Contact Details |
|---|
We get it. You are running a business and dont have time or money to waste. You need practical outside counsel that helps you get the right result without undue disruption or expense. We know that you need to realistically assess the risks in any given situation, decide on an approach that suits your business objectives, and execute successfully. Usually fast. Frequently yesterday. Our team brings a uniquely business-savvy perspective and valuable insight borne of substantial in-house experience as well as a level of client service honed by years of building highly successful client relationships as outside counsel. Put simply, we treat our clients like we dreamed of being treated when we were in-house. We deliver. Members of our team have led the charge on corporate and employment law aspects of some of the biggest mergers of their time and seen to successful integration once the deals were done. Weve served as outside counsel handling all varieties of corporate matters and managed major dockets of litigation, helped clients dramatically reduce such claims before they are filed, handled administrative charges nationwide, dealt with boards and senior leadership in "bet the company" scenarios and been joined at the hip with in-house counsel, human resources professionals, and managers in the front lines. Weve been the go-to resources on mission-critical and day-to-day issues as well as everything in between. We can help you anticipate the next big issue, identify opportunities, avoid unintended consequences, exceed expectations, and maintain the trust and confidence of your internal clients – something we know you worked hard to build. Lets talk. We would love to hear what you have going on and what you see as trends, primary challenges and next issues. We always want to learn more about your business. We want to help you in your mission to add value. And when you are ready, lets talk about how we can help your team.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.
Ethos is a life insurance company founded in 2016 by Peter Colis and Lingke Wang. The company focuses on making life insurance more affordable and accessible by using technology to simplify the application process. Ethos operates as a licensed insurance agency, partnering with third-party carriers like Legal & General America, TruStage, and Ameritas. Ethos offers an online application process that provides instant quotes, allowing customers to apply for life insurance quickly. The company utilizes a proprietary underwriting engine to assess health and eligibility, ensuring suitable coverage options. Ethos also supports a network of independent insurance agents, facilitating both direct-to-consumer and agent-assisted sales. The primary product offered is term life insurance, tailored to meet individual needs. With significant funding from investors such as Sequoia, Accel, Google Ventures, Goldman Sachs, and Softbank, Ethos has established itself as a major player in the U.S. life insurance market, aiming to protect millions of families.